Curaleaf Holdings (CURLF) EBITDA Margin (2019 - 2026)
Curaleaf Holdings (CURLF) recorded quarterly EBITDA Margin of 0.23% in Q1 2026, up 100.0% quarter-over-quarter from 47701321.71% in Q4 2025, and down 282.0% on a YoY basis from 0.13% in Q1 2025.
Curaleaf Holdings (CURLF) EBITDA Margin (2019 - 2026) Analysis & Trends
Curaleaf Holdings' EBITDA Margin history runs 8 years deep, the most recent figure standing at 0.23% for Q1 2026.
- In Q1 2026, EBITDA Margin fell 282.0% year-over-year to 0.23%; the TTM figure through Mar 2026 stood at 47764.71% (down 4776635.0% YoY), while the FY2025 annual figure was 8.62%, up 53.0% from the prior year.
- EBITDA Margin was 0.23% for Q1 2026 at Curaleaf Holdings, up from 47701321.71% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 22.74% in Q3 2022 to a low of 47701321.71% in Q4 2025.
- Historically, EBITDA Margin has averaged 5947513.9% across 5 years, with a median of 1.73% in 2025.
- The sharpest annual moves came in 2022 and 2025: EBITDA Margin soared 4296 bps in 2022, then slumped 2000000000 bps in 2025.
- A 5-year view of EBITDA Margin shows it stood at 23.21% in 2022, then soared by 117 bps to 4.05% in 2023, then tumbled by 136 bps to 1.47% in 2024, then tumbled by 2000000000 bps to 47701321.71% in 2025, then surged by 100 bps to 0.23% in 2026.
- The last three EBITDA Margin figures came in at 0.23% (Q1 2026), 47701321.71% (Q4 2025), and 1.26% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -1.01% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 22.74% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -170.35% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 21.55% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -16.25% |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | 0.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.23% |
| Dec 31, 2025 | -47,701,321.71% |
| Sep 30, 2025 | 1.26% |
| Jun 30, 2025 | -47,458,936.62% |
| Mar 31, 2025 | 3.05% |
| Dec 31, 2024 | -1.47% |
| Sep 30, 2024 | 2.79% |
| Jun 30, 2024 | 2.20% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 4.05% |
| Sep 30, 2023 | 4.57% |
| Jun 30, 2023 | -1.27% |
| Dec 31, 2022 | -23.21% |
| Sep 30, 2022 | 22.74% |
| Jun 30, 2022 | 12.30% |
| Mar 31, 2022 | 8.63% |
| Dec 31, 2021 | -11.19% |
| Sep 30, 2021 | -20.22% |
| Jun 30, 2021 | 1.97% |
| Mar 31, 2021 | 5.70% |